April 7, 2024Journal of the American College of Cardiology
Artificial Intelligence for Cardiovascular Care—Part 1: Advances
Pierre EliasSneha S. JainTimothy J. PoteruchaMichael RandazzoFrancisco López JiménezRohan KheraMarco PerezDavid OuyangJames P. PirruccelloMichael SalernoAndrew J. EinsteinRobert AvramGeoffrey H. TisonGirish N. NadkarniVivek T. NatarajanEmma PiersonAshley BeecyDeepa KumaraiahChris HaggertyJennifer N. Avari SilvaThomas M. Maddox
Journal of the American College of Cardiology published a graphical abstract
Its licence doesn't allow us to show a copy here.
Why the study?
Despite growing numbers of studies in cardiovascular AI, trials showing improvement in patient outcomes remain lacking, necessitating rigorous validation of its efficacy, equity, and reliability.
Key Points
Key points are not available for this paper at this time.
Design
Review
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“AI technologies have shown early promise in screening for disease, integrating disparate imaging data sources into composite assessments, providing workflow efficiencies through preprocessing of images, and assisting clinicians with more accurate diagnoses.”
“Realizing the potential for AI in cardiovascular medicine will require a concerted effort by our cardiology community to develop, test, and implement these technologies into our practice, continually evaluating where AI can and cannot provide significant value.”
Implication
AI advancements in cardiovascular care show high diagnostic accuracy, but rigorous validation and outcome-driven trials are required before widespread clinical adoption.
Abstract
Recent AI advancements in cardiovascular care offer potential enhancements in diagnosis, treatment, and outcomes. Innovations to date focus on automating measurements, enhancing image quality, and detecting diseases using novel methods. Applications span wearables, electrocardiograms, echocardiography, angiography, genetics, and more. AI models detect diseases from electrocardiograms at accuracy not previously achieved by technology or human experts, including reduced ejection fraction, valvular heart disease, and other cardiomyopathies. However, AI's unique characteristics necessitates rigorous validation by addressing training methods, real-world efficacy, equity concerns, and long-term reliability. Despite an exponentially growing number of studies in cardiovascular AI, trials showing improvement in outcomes remain lacking. A number are currently underway. Embracing this rapidly evolving technology while setting a high evaluation benchmark will be crucial for cardiology to leverage AI to enhance patient care and the provider experience.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Elias et al. (2024) studied this question.